In the BioHarmony Drug Report Database

"Preview" Icon

Eplerenone

Inspra (eplerenone) is a small molecule pharmaceutical. Eplerenone was first approved as Inspra on 2002-09-27. It is used to treat hypertension and systolic heart failure in the USA. The pharmaceutical is active against mineralocorticoid receptor.

 

Trade Name

 

Inspra
 

Common Name

 

eplerenone
 

ChEMBL ID

 

CHEMBL1095097
 

Indication

 

hypertension, systolic heart failure
 

Drug Class

 

Aldosterone antagonists (spironolactone type)

Image (chem structure or protein)

Eplerenone structure rendering